Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models

• NASDAQ: $APM
• Notified: $2.02
• 02:01 EDT